MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson-related CHCHD2 is necessary for oligomerization of ALS/FTD-related CHCHD10

D. Narendra, X. Huang, B. Wu, Y. Liu, D. Nguyen, M. Marani (Bethesda, MD, USA)

Meeting: 2018 International Congress

Abstract Number: 1369

Keywords: Familial neurodegenerative diseases, Frontotemporal dementias: Genetics, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: Characterization of isogenic CHCHD2, CHCHD10, and CHCHD2/10 double knockout out cell lines with assays of mitochondrial function, mitochondrial sublocalization, and homo- and heterodimerization.

Background: Mutations in paralogous mitochondrial proteins CHCHD2 and CHCHD10 were recently found to cause autosomal dominant Parkinson Disease (PD) and ALS/FTD, respectively. The proteins exhibit 58% amino acid sequence identity and are thought to have resulted from a gene duplication event. Additionally, most pathogenically proven missense mutations in CHCHD2 (including T61I) and CHCHD10 (including G58R, S59L, and G66V) cluster in the same highly conserved region. The extent to which the proteins have retained a common function in their divergent evolution, however, is not known. To this end, we generated CHCHD2 KO, CHCHD10 KO, and CHCHD2/10 double KO cells on an isogenic background to allow direct comparison of CHCHD2 and CHCHD10 localization and function.

Methods: Isogenic CHCHD2, CHCHD10, and CHCHD2/10 double knockout cell lines were generated on a HEK293 and HeLa cell background by Crispr/Cas9. Localization was assessed using confocal, stimulated emission depletion (STED), and immuno-electron microscopy. Mitochondrial protein expression was assessed by immunoblotting and mitochondrial function was assessed using the Seahorse oxygen consumption assay. Homo- and heterodimerization of CHCHD2 and CHCHD10 was assessed in co-immunoprecipitation and crosslinking studies.

Results: We find that CHCHD2 and CHCHD10 are partially functionally redundant, share localization throughout mitochondrial cristae, and form heterodimers. CHCHD2 is strictly required for oligomerization of CHCHD10. CHCHD2, in contrast to CHCHD10, readily forms homodimers in the absence of CHCHD10, which may account for the more severe phenotype resulting from loss of CHCHD2. We exploit the dependence of CHCHD10 oligomerization on CHCHD2 to develop a CHCHD2/CHCHD10 heterodimer incorporation assay and demonstrate that CHCHD2 and CHCHD10 with disease-causing mutations readily incorporate into heterodimers.

Conclusions: CHCHD2 and CHCHD10 have retained a similar function and directly interact. Notably, CHCHD10 is dependent on CHCHD2 for oligomerization. Disease-causing mutations do not disrupt the direct interaction of CHCHD2 and CHCHD10 and suggest a mechanism by which pathogenic mutations in CHCHD2 could directly affect functioning of wildtype CHCHD10 and vice versa.

To cite this abstract in AMA style:

D. Narendra, X. Huang, B. Wu, Y. Liu, D. Nguyen, M. Marani. Parkinson-related CHCHD2 is necessary for oligomerization of ALS/FTD-related CHCHD10 [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/parkinson-related-chchd2-is-necessary-for-oligomerization-of-als-ftd-related-chchd10/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinson-related-chchd2-is-necessary-for-oligomerization-of-als-ftd-related-chchd10/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley